Abstract:miRNAs represent a class of small non-coding RNAs that can regulate the stability and translation of specific mRNA targets. Several members of the let-7 miRNA family are down-regulated in ovarian and other cancers and are thought to act as tumor suppressors, possibly through their ability to target growth-promoting genes (RAS, HMGA2), cell cycle genes (CDK6, CDK7, STK6, STK12), and anti-apoptotic genes (Bcl-2, casp3). However, the exact mechanisms regulating their expression and activity are not clearly known. In order to address this issue, we have developed a reporter assay for let-7 activity. We have made several reporter constructs containing the luciferase gene attached to different site combinations and sequences of let-7 in its 3′ UTR, and have identified a reporter that is extremely sensitive to let-7 activity. Ovarian cancer cell lines BG1 and UCI101 were transfected with the let-7 reporter and treated with 80 different kinase inhibitors in order to identify upstream pathways that can affect let-7 activity. We found nine inhibitors which caused consistent, dose-dependent changes on endogenous let-7 activity. The nine drugs can be categorized into three classes of inhibitors and further validation is currently underway through knockdowns of specific kinases. Our findings suggest novel molecular pathways involved in the regulation of let-7 family and, considering the important role of let-7 family members in ovarian cancer, these pathways may further our understanding of ovarian tumorigenesis and provide new targets for therapy. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2310. doi:1538-7445.AM2012-2310

Short loop-targeting oligoribonucleotides antagonize Lin28 and enable pre-let-7 processing and suppression of cell growth in let-7-deficient cancer cells

Microrna Let-7g and Let-7i Inhibit Hepatoma Cell Growth Concurrently Via Downregulation of the Anti-Apoptotic Protein B-Cell Lymphoma-Extra Large

Oncogenic Mechanisms of Lin28 in Breast Cancer: New Functions and Therapeutic Opportunities.

Advances in Targeting the LIN28/Let-7 Pathway

Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy

Short 2′- O -methyl/LNA oligomers as highly-selective inhibitors of miRNA production in vitro and in vivo

Mir-203 Enhances Let-7 Biogenesis by Targeting LIN28B to Suppress Tumor Growth in Lung Cancer

Data from the &Lt;i>let-7&Lt;/i> MicroRNA Represses Cell Proliferation Pathways in Human Cells

The role of Lin28A and Lin28B in cancer beyond Let‐7

Specific Interaction Between Lin28 And Pri-Let-7g

Targeted Inhibition of Oncogenic Mir-21 Maturation with Designed RNA-binding Proteins.

Identification of Micrornas Regulating Reprogramming Factor Lin28 in Embryonic Stem Cells and Cancer Cells

Abstract 2310: Identification of Signaling Pathways Involved in the Regulation of Let-7 in Ovarian Cancer

Development of a molecular glue-based Lin28 degrader to regulate cellular proliferation and stemness

Targeted Delivery of Let-7B to Reprogramme Tumor-Associated Macrophages and Tumor Infiltrating Dendritic Cells for Tumor Rejection

Lin-28B Transactivation is Necessary for Myc-mediated Let-7 Repression and Proliferation

Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer

Elucidating the Role of Let-7d-5p and OLR1 in the Progression and Prognosis of Oral Squamous Cell Carcinoma via FAK/P53 Signaling Axis

Structural basis for activity switching in polymerases determining the fate of let-7 pre-miRNAs

A Single Anti-Microrna Antisense Oligodeoxyribo-Nucleotide (Amo) Targeting Multiple Micrornas Offers An Improved Approach For Microrna Interference

Discovery of novel microRNA mimic repressors of ribosome biogenesis